TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive In brief: ring appointed Associate Dean At UCSF; Univ. of Utah Forms Cell Signaling Center August 1, 1997